
IRadimed Corp
NASDAQ:IRMD

IRadimed Corp?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
39.9713
62.67
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does IRadimed Corp hold over its rivals?
What risks and challenges
does IRadimed Corp face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of IRadimed Corp.
Provide an overview of the primary business activities
of IRadimed Corp.
What unique competitive advantages
does IRadimed Corp hold over its rivals?
What risks and challenges
does IRadimed Corp face in the near future?
Has there been any significant insider trading activity
in IRadimed Corp recently?
Summarize the latest earnings call
of IRadimed Corp.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for IRadimed Corp.
Provide P/S
for IRadimed Corp.
Provide P/E
for IRadimed Corp.
Provide P/OCF
for IRadimed Corp.
Provide P/FCFE
for IRadimed Corp.
Provide P/B
for IRadimed Corp.
Provide EV/S
for IRadimed Corp.
Provide EV/GP
for IRadimed Corp.
Provide EV/EBITDA
for IRadimed Corp.
Provide EV/EBIT
for IRadimed Corp.
Provide EV/OCF
for IRadimed Corp.
Provide EV/FCFF
for IRadimed Corp.
Provide EV/IC
for IRadimed Corp.
Show me price targets
for IRadimed Corp made by professional analysts.
What are the Revenue projections
for IRadimed Corp?
How accurate were the past Revenue estimates
for IRadimed Corp?
What are the Net Income projections
for IRadimed Corp?
How accurate were the past Net Income estimates
for IRadimed Corp?
What are the EPS projections
for IRadimed Corp?
How accurate were the past EPS estimates
for IRadimed Corp?
What are the EBIT projections
for IRadimed Corp?
How accurate were the past EBIT estimates
for IRadimed Corp?
Compare the revenue forecasts
for IRadimed Corp with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of IRadimed Corp and its key competitors using the latest financial data.
Compare historical revenue growth rates
of IRadimed Corp against its competitors.
Analyze the profit margins
(gross, operating, and net) of IRadimed Corp compared to its peers.
Compare the P/E ratios
of IRadimed Corp against its peers.
Discuss the investment returns and shareholder value creation
comparing IRadimed Corp with its peers.
Analyze the financial leverage
of IRadimed Corp compared to its main competitors.
Show all profitability ratios
for IRadimed Corp.
Provide ROE
for IRadimed Corp.
Provide ROA
for IRadimed Corp.
Provide ROIC
for IRadimed Corp.
Provide ROCE
for IRadimed Corp.
Provide Gross Margin
for IRadimed Corp.
Provide Operating Margin
for IRadimed Corp.
Provide Net Margin
for IRadimed Corp.
Provide FCF Margin
for IRadimed Corp.
Show all solvency ratios
for IRadimed Corp.
Provide D/E Ratio
for IRadimed Corp.
Provide D/A Ratio
for IRadimed Corp.
Provide Interest Coverage Ratio
for IRadimed Corp.
Provide Altman Z-Score Ratio
for IRadimed Corp.
Provide Quick Ratio
for IRadimed Corp.
Provide Current Ratio
for IRadimed Corp.
Provide Cash Ratio
for IRadimed Corp.
What is the historical Revenue growth
over the last 5 years for IRadimed Corp?
What is the historical Net Income growth
over the last 5 years for IRadimed Corp?
What is the current Free Cash Flow
of IRadimed Corp?
Discuss the annual earnings per share (EPS)
trend over the past five years for IRadimed Corp.
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
US |
![]() |
IRadimed Corp
NASDAQ:IRMD
|
664.6m USD | 34.6 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
221B USD | 16.4 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
175.8B USD | 75.7 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
138.4B USD | 74.5 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
133.8B USD | 44.6 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
106.5B USD | 25 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
58.8B USD | 33.5 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
48.6B EUR | 24.5 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
40.6B USD | 9.8 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
260.6B CNY | 21 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
31.9B USD | 35.9 |
|
Earnings Growth | PEG | |||||
---|---|---|---|---|---|---|
US |
![]() |
IRadimed Corp
NASDAQ:IRMD
|
Average P/E:
36
34.6
|
N/A | N/A | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
16.4
|
-6%
|
N/A |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
75.7
|
20%
|
3.8 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
74.5
|
44%
|
1.7 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
44.6
|
28%
|
1.6 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
25
|
30%
|
0.8 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
33.5
|
42%
|
0.8 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
24.5
|
23%
|
1.1 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
9.8
|
-24%
|
N/A |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
21
|
15%
|
1.4 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
35.9
|
13%
|
2.8 |
|
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.